InflaRx to Report Second Quarter 2026 Results on August 6, 2026
InflaRx N.V. (Nasdaq: IFRX) announced that it will report its second-quarter 2026 financial and operating results on August 6, 2026, before the market opens. The company pioneers anti-inflammatory therapeutics and will not be hosting a conference call.